Dual Antiplatelet Therapy After Heart Bypass Surgery Offers No Added Benefit over Aspirin Alone

Dual antiplatelet therapy after heart bypass surgery offers no added benefit over aspirin alone

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at 22 Nordic heart surgery units.

No support found for dual antiplatelet therapy after cardiac bypass surgery over aspirin alone

Dual antiplatelet therapy after cardiac bypass surgery is no more effective than acetylsalicylic acid alone and also increases the risk of serious bleeding. This is shown in a study by researchers at Karolinska Institutet and the University of Gothenburg published in the journal the New England Journal of Medicine.

ESC 2025: Studies shed new light on antiplatelet therapy after CABG surgery - Cardiovascular News

Anders Jeppsson New evidence offers fresh insights into the merits of dual antiplatelet therapy (DAPT) following coronary artery bypass graft (CABG) surgery and calls into question current guideline recommendations for anticoagulation post-bypass, according to investigators. TOP-CABG and TACSI were among two hot line trials presented during the final day of the 2025 European Society of Cardiology (ESC) congress (29 August–1 September, Madrid, Sp…